Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver Disease

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 6, 2014, Pages 1706-1711

  Stewart, Scott H ^a   Koch, David G ^b   Willner, Ira R ^b   Anton, Raymond F ^b   Reuben, Adrian ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alcohol Drinking; Biomarker; Liver Disease; Phosphatidylethanol

Indexed keywords

ALCOHOL DERIVATIVE; PHOSPHATIDYLETHANOL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GLYCEROPHOSPHOLIPID;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; AUTOIMMUNE LIVER DISEASE; BLOOD SAMPLING; CHRONIC LIVER DISEASE; DISEASE SEVERITY; FALSE POSITIVE RESULT; FEMALE; GRANULOMATOSIS; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; LIMIT OF QUANTITATION; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SELF REPORT; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; AGE; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; DRINKING BEHAVIOR; LIVER DISEASE; MIDDLE AGED; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE;

ADULT; AGE FACTORS; ALCOHOL DRINKING; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; FEMALE; GLYCEROPHOSPHOLIPIDS; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 84901918502     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12442     Document Type: Article

References (29)

1. Allen JP, Wurst FM, Thon N, Litten RZ (2013) Assessing the drinking status of liver transplant patients with alcoholic liver disease. Liver Transpl 19:369-376.
2. Alling C, Gustavsson L, Anggard E (1983) An abnormal phospholipid in rat organs after ethanol treatment. FEBS Lett 152:24-28.
3. Aradottir S, Asanovska G, Gjerss S, Hansson P, Alling C (2006) Phosphatidylethanol (PEth) concentrations in blood are correlated to reported alcohol intake in alcohol-dependent patients. Alcohol Alcohol 41:431-437.
4. Arndt T, van der Meijden BB, Wielders JP (2008) Atypical serum transferrin isoform distribution in liver cirrhosis studied by HPLC, capillary electrophoresis and transferrin genotyping. Clin Chim Acta 394:42-46.
5. Dresen S, Weinmann W, Wurst FM (2004) Forensic confirmatory analysis of ethyl sulfate-a new marker for alcohol consumption-by liquid-chromatography/electrospray ionization/tandem mass spectrometry. J Am Soc Mass Spectrom 15:1644-1648.
6. Faller A, Richter B, Kluge M, Koenig P, Seitz HK, Thierauf A, Gnann H, Winkler M, Mattern R, Skopp G (2011) LC-MS/MS analysis of phosphatidylethanol in dried blood spots versus conventional blood specimens. Anal Bioanal Chem 401:1163-1166.
7. Gnann H, Weinmann W, Thierauf A (2012) Formation of phosphatidylethanol and its subsequent elimination during an extensive drinking experiment over 5 days. Alcohol Clin Exp Res 36:1507-1511.
8. Gustavsson L (1995) Phosphatidylethanol formation: specific effects of ethanol mediated via phospholipase D. Alcohol Alcohol 30:391-406.
9. Hahn JA, Dobkin LM, Mayanja B, Emenyonu NI, Kigozi IM, Shiboski S, Bangsberg DR, Gnann H, Weinmann W, Wurst FM (2012) Phosphatidylethanol (PEth) as a biomarker of alcohol consumption in HIV-positive patients in sub-Saharan Africa. Alcohol Clin Exp Res 36:854-862.
10. Hansson P, Caron M, Johnson G, Gustavsson L, Alling C (1997) Blood phosphatidylethanol as a marker of alcohol abuse: levels in alcoholic males during withdrawal. Alcohol Clin Exp Res 21:108-110.
11. Hartmann S, Aradottir S, Graf M, Wiesbeck G, Lesch O, Ramskogler K, Wolfersdorf M, Alling C, Wurst FM (2007) Phosphatidylethanol as a sensitive and specific biomarker: comparison with gamma-glutamyl transpeptidase, mean corpuscular volume and carbohydrate-deficient transferrin. Addict Biol 12:81-84.
12. Helander A, Husa A, Jeppsson JO (2003) Improved HPLC method for carbohydrate-deficient transferrin in serum. Clin Chem 49:1881-1890.
13. Helander A, Peter O, Zheng Y (2012) Monitoring of the alcohol biomarkers PEth, CDT, and EtG/EtS in an outpatient treatment setting. Alcohol Alcohol 47:552-557.
14. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464-470.
15. Morini L, Politi L, Groppi A, Stramesi C, Polettini A (2006) Determination of ethyl glucuronide in hair samples by liquid chromatography/electrospray tandem mass spectrometry. J Mass Spectrom 41:34-42.
16. Pragst F, Rothe M, Moench B, Hastedt M, Herre S, Simmert D (2010) Combined use of fatty acid ethyl esters and ethyl glucuronide in hair for diagnosis of alcohol abuse: interpretation and advantages. Forensic Sci Int 196:101-110.
17. Shushan B (2010) A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry. Mass Spectrom Rev 29:930-944.
18. Skipper GE, Thon N, Dupont RL, Baxter L, Wurst FM (2013) Phosphatidylethanol: the potential role in further evaluating low positive urinary ethyl glucuronide and ethyl sulfate results. Alcohol Clin Exp Res 37:1582-1586.
19. Sobell L, Sobell M (1992) Timeline follow-back: a technique for assessing self-reported ethanol consumption, in Measuring Alcohol Consumption: Psychological and Biological Methods (Litten RZ, Allen JP eds), pp 41-72. Humana Press, Totowa, NJ.
20. Staufer K, Andresen H, Vettorazzi E, Tobias N, Nashan B, Sterneck M (2011) Urinary ethyl glucuronide as a novel screening tool in patients pre and post liver transplantation improves detection of alcohol consumption. Hepatology 54:1640-1649.
21. Stewart SH, Bowen E, Comte-Walters S, Anton RF (2010a) Liver disease and HPLC-quantification of disialotransferrin for heavy alcohol use: a case series. Alcohol Clin Exp Res 34:1956-1960.
22. Stewart SH, Koch DG, Burgess DM, Willner IR, Reuben A (2013a) Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients. Alcohol Clin Exp Res 37:150-155.
23. Stewart SH, Koch DG, Willner IR, Randall PK, Reuben A (2013b) Hair ethyl glucuronide is highly sensitive and specific for detecting moderate-to-heavy drinking in patients with liver disease. Alcohol Alcohol 48:83-87.
24. Stewart SH, Law TL, Randall PK, Newman R (2010b) Phosphatidylethanol and alcohol consumption in reproductive age women. Alcohol Clin Exp Res 34:488-492.
25. Stewart SH, Reuben A, Brzezinski WA, Koch DG, Basile J, Randall PK, Miller PM (2009) Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension. Alcohol Alcohol 44:464-467.
26. Varga A, Hansson P, Lundqvist C, Alling C (1998) Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers. Alcohol Clin Exp Res 22:1832-1837.
27. Wurst FM, Alling C, Aradottir S, Pragst F, Allen JP, Weinmann W, Marmillot P, Ghosh P, Lakshman R, Skipper GE, Neumann T, Spies C, Javors M, Johnson BA, Ait-Daoud N, Akhtar F, Roache JD, Litten R (2005) Emerging biomarkers: new directions and clinical applications. Alcohol Clin Exp Res 29:465-473.
28. Wurst FM, Thon N, Aradottir S, Hartmann S, Wiesbeck GA, Lesch O, Skala K, Wolfersdorf M, Weinmann W, Alling C (2010) Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports. Addict Biol 15:88-95.
29. Yoon Y, Yi H (2010) Surveillance Report #88. Liver Cirrhosis Mortality in the United States, 1970-2007. US Department of Health and Human Services, Bethesda, MD.